ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
31 Mar 2020 17:32

Korea Stock Market Monthly Recap #46 (March 2020)

The world will never be the same after COVID-19. We provided an extensive analysis of the on-going developments of COVID-19 in March. This novel...

Logo
304 Views
Share
31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
347 Views
Share
24 Mar 2020 17:51

Short Covering - The New Normal

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 20 March 2020, the...

Logo
332 Views
Share
24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
300 Views
Share
17 Mar 2020 17:37

Short Selling - The Last Hurrah

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 13 March 2020, the...

Logo
325 Views
Share
x